AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. ANAB currently screens at market cap $1.62B.
Use this ANAB page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ANAB quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ANAB SEC filings page. Lician reads the product cache first so this HTML stays unique to AnaptysBio Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ANAB income, balance, and cash tables.